Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up

The present study evaluated the incidence of cardiovascular events (CVEs) in 63 chronic myeloid leukemia (CML) patients after long-term exposure to nilotinib. By considering the effect of cardiovascular risk factors and defining CVEs according to the current 2014 American College of Cardiology/American Heart Association recommendations, the present study attempted to overcome the previous limitations in reporting CVEs in CML patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research